Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 2/20 | 0.35 |
| ▸ | RAB9A | P51151 | 2/20 | 0.35 |
| ▸ | CTSA | P10619 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
| ▸ | GAA | P10253 | 2/20 | 0.34 |
| ▸ | CASP3 | P42574 | 2/20 | 0.34 |
| ▸ | SENP8 | Q96LD8 | 2/20 | 0.34 |
| ▸ | SENP7 | Q9BQF6 | 2/20 | 0.34 |
| ▸ | SENP6 | Q9GZR1 | 2/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.34 |
| ▸ | WNT3A | P56704 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1012187 | 0.72 | CES2 (0.52) | RAB9AALDH1A1MAPT | |
| SCHEMBL1012189 | 0.72 | CES2 (0.52) | RAB9AALDH1A1MAPT | |
| SCHEMBL9964038 | 0.72 | CTNNB1 (0.48) | NPC1RAB9AKDM4EALDH1A1GAA | |
| SCHEMBL15863170 | 0.71 | CYP11B1 (0.42) | KDM4EALDH1A1GAACASP3SENP8 | |
| SCHEMBL15863169 | 0.71 | CYP11B1 (0.42) | KDM4EALDH1A1GAACASP3SENP8 | |
| SCHEMBL15863598 | 0.71 | CYP11B1 (0.42) | KDM4EALDH1A1GAACASP3SENP8 | |
| SCHEMBL19971377 | 0.68 | PIK3C3 (0.33) | L3MBTL1 | |
| SCHEMBL10514737 | 0.68 | ALDH1A1 (0.50) | NPC1RAB9AKDM4EALDH1A1MAPT | |
| SCHEMBL1931609 | 0.68 | CES2 (0.47) | NPC1RAB9AKDM4EALDH1A1POLB | |
| SCHEMBL209954 | 0.68 | KDM4E (0.61) | RAB9AKDM4EALDH1A1GAAHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140171316-A1 | ANTHRANILAMIDE COMPOUNDS AND THEIR USE AS PESTICIDES | BASF SE (DE) | 2014-06-19 | — | — | US | disclosed |
| EP-2742038-A1 | ANTHRANILAMIDE COMPOUNDS AND THEIR USE AS PESTICIDES | BASF SE (DE) | 2014-06-18 | — | — | EP | disclosed |
| EP-2742027-A1 | N-THIO-ANTHRANILAMIDE COMPOUNDS AND THEIR USE AS PESTICIDES | BASF SE (DE) | 2014-06-18 | — | — | EP | disclosed |
| US-20140162875-A1 | N-Thio-Anthranilamide Compounds and Their Use as Pesticides | BASF SE (DE) | 2014-06-12 | — | — | US | disclosed |
| WO-2013024004-A1 | N-THIO-ANTHRANILAMIDE COMPOUNDS AND THEIR USE AS PESTICIDES | BASF SE (DE) | 2013-02-21 | — | — | WO | disclosed |
| WO-2013024006-A1 | ANTHRANILAMIDE COMPOUNDS AND THEIR USE AS PESTICIDES | BASF SE (DE) | 2013-02-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140162875-A1 | N-Thio-Anthranilamide Compounds and Their Use as Pesticides | ANTXR2, NIT2, TXN | NPC1 4483/4885RAB9A 2088/4885CTSA 3288/4885 |
| US-20140171316-A1 | ANTHRANILAMIDE COMPOUNDS AND THEIR USE AS PESTICIDES | ANTXR2, NQO2, AAAS | NPC1 4767/4885RAB9A 1446/4885CTSA 2612/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.